AI Nova Dx, based in Waltham, Massachusetts, is a specialized consulting and molecular assay development firm dedicated to advancing innovation in molecular detection of target analytes Ex. Bacteria, viral, fungal and parasites. The company is led by a group of experienced scientists with deep expertise in cutting edge molecular biology, qPCR technology, ddPCR, assay development, and commercialization. Together, we provide scientific, regulatory, and strategic guidance to both emerging and established companies.

Using our research use only (RUO) products, we support diagnostic organizations by accelerating assay development, optimizing laboratory workflows, strengthening regulatory strategies, and enabling successful commercialization. Our mission is to empower diagnostic developers to move from concept to clinical impact with greater efficiency, precision, and confidence, translating scientific discoveries into robust, high-performance real time solutions.